Professional Documents
Culture Documents
CHF Nyha III Ec. Alcoholic Cardiomyopathy
CHF Nyha III Ec. Alcoholic Cardiomyopathy
PATIENT IDENTITY
Name
: Mr S
Age
: 56 years old
Gender
: Male
Admission date : 09-03-2016
HISTORY TAKING
Chief Complaint : Shortness of breath
Felt since approx. 2 weeks ago and worsen 2 days before being admitted to
the hospital. Experienced while doing minimal activity such as walking to the
bathroom and is relieved with rest.
At times patient get startled during the night due to sudden onset of
shortness of breath.
No chest pain
Heartburn (-)
Cough (-).
RISK FACTORS
Non- Modified
Modified
Smoking
Alcohol
consumption
General Status
* Moderate illness/ Well nourished/ Conscious
* Nutritional Status: Normal
* Weight : 67 kg
* Height : 163 cm
: 25.21 kg/m2
* BMI
Vital Sign
* Blood Pressure
:
* Pulse Rate
* Respiratory Rate
* Temperature
: 90/60 mmHg
82 bpm
: 26 bpm
: 36.6 0C (axilla)
PHYSICAL EXAMINATION
Head and Neck Examinations
Eye
: Conjunctiva anemic (-/-), Sclera icteric
(-/-)
Lip
: Cyanosis (-)
Neck
: JVP R +3 cmHO
Chest Examination
Inspection : Symmetric between left and right
chest.
Palpation : No mass, no tenderness.
Percussion : Sonor between left and right chest,
lung-liver border is ICS IV right anterior.
Auscultation: Respiratory sound: Vesicular
Additional sound :Ronchi +/+
mediobasal,Wheezing -/-
Heart
Abdomen
Inspection
Palpation
Percussion
Auscultation
Inspection
: Distended, follows breathing
movement
Auscultation
: Peristaltic sound (+), normal
Palpation
: No mass, no tenderness, liver palpable
4cm from arcus costa and spleen unpalpable
Percussion
: Tympani (+)
Extremities
ECG
interpretation
Radiology findings
LABORATORY FINDINGS
PEMERIKSAAN
NILAI
NILAI RUJUKAN
UNIT
WBC
7.8
4.00-10.00
103/ul
RBC
5.25
4.00-6.00
106/ul
Hb
16.1
12.0-16.0
gr/dl
Plt
112
150-400
103/ul
PT
22.7
10-14
Detik
APTT
30.6
22.0-33.0
Detik
INR
1.98
--
GDS
90
140
mg/dl
Ureum
113
10-50
mg/dl
Creatinin
1.28
L(<1.3) P(<1.1)
mg/dl
SGOT
578
<38
U/L
SGPT
492
<41
U/L
963.00
L(<190), P (<167)
U/L
CKMB
49.0
<25
U/L
Troponin I
0.65
<0.01
ng/ml
Natrium
129
136-145
mmol/l
Kalium
4.8
3.5-5.1
mmol/l
Klorida
100
97-111
mmol/l
CK
7.539
7.35-7.45
pCO2
32.0
mmHg
SO2
96.8
PO2
77.9
80.0-100.0
mmHg
HCO3
27.6
22-26
mmol/l
ctO2
23.4
Vol%
ctCO2
28.5
mmol/l
BE
4.8
-2 sd +2
mmol/l
Working
DIAGNOSIS
Chf nyha iII ec.
MODERATE
ALCOHOLIC
CARDIOMYOPATHY
MANAGEMENT
Bed rest
Oxygen 3-4 lpm via nasal canule
IVFD NaCl 0.9% 500 cc/24 hr
Diuretic
Furosemid 2 amp/8 hr/iv
ACE Inhibitor
Captopril 12.5mg/8hr/oral
Expectorant
Ambroxol 20mg/8hr/oral
DISCUSSION
HEART FAILURE
DEFINITION
rt
a
e
H
ure
l
i
a
F
Heart is no longer able to pump an
adequate supply of blood in relation
to the venous return and in relation
to the metabolic needs of the body
tissues at the particular moment
ve
i
t
s
ge
Con art
He e
ur
F ai l
ETIOLOGY OF
HEARTFAILURE
Myocard
Disease
CAD
Cardiomyopathy
Iatrogenic
Miocarditis
Myocard Mechanical
Dysfunction
Pressure overloaded
(Stenosis Aortae, Hypertension,
Coartatio Aortae)
Volume Overloaded
(Mitral/Aortae Regurgitation,
Congenital Heart Disease,
Hipertransfusion)
Extremity edema
Dyspnea
Nocturnal cough
Cardiomegaly
Gallop S3
Hepatojugular reflux
Hepatomegaly
Increased of JVP
Pleural effusion
Rales or ronchi
Tachycardia ( 120bpm)
Dyspnea deffort
25 sec)
*Signs of CHF
clASSIFICATION OF
CHF
*PATHOPHYSIOLOGY OF CHF
CHF MANAGEMENT
Optimalized
Oxigenation
NonFarmakologi
Reduce Physical
Activity
Low salt, enough
calories and proteins
detary
Fluid restriction
CHF MANAGEMENT
Farmakologi
Managing preload
Managing afterload
Managing
contractility
Neurohormonal
modulation
Diuretics
Venodilator
Inotropic agents :
Cardiac glycosides
B- adrenergic
ACE inhibitors
ARB
blockers
CCB
blockers
ACE
inhibitors
ARB
Medical Therapy
*ACE-Inhibitor
*Digitalis
*Diuretic
*Anti-arrhytmia
*Digoxin
*Anti-coagulant
*Antibiotic
Surgical intervention
Thank You